Takatsu K, Harada N, Hara Y, Takahama Y, Yamada G, Dobashi K, Hamaoka T
J Immunol. 1985 Jan;134(1):382-9.
Murine T cell replacing factor (TRF) was purified from a cellfree supernatant of a T cell hybridoma (B151K12) that constitutively produces TRF. Two assay systems for TRF activity were employed: 1) induction of anti-DNP IgG PFC responses in cultures of splenic B cells from DNP-KLH-primed BALB/c mice, and 2) induction of IgM PFC in chronic B cell leukemic cells (BCL1). The purification scheme consisted of ammonium sulfate precipitation, DEAE-cellulose chromatography, Blue-Sepharose chromatography, hydroxylapatite chromatography, gel permeation with fast protein liquid chromatography (FPLC), and disc polyacrylamide gel electrophoresis. Overall, TRF was purified approximately 34,000-fold with a maximum 3.8% recovery of activity, and the specific activity of the purified TRF was approximately 9.6 X 10(4) U/mg. The TRF that is active in these systems is distinct from the other lymphokines such as IL 1, IL 2, BCGFI (now known as BSFp1), and gamma-interferon. The TRF is extremely hydrophobic, with an apparent m.w. of 50,000 to 60,000 on gel permeation chromatography and 18,000 on SDS-PAGE under reducing conditions. Highly purified B151-TRF abrogated the activity by treatment with trypsin but not with RNase. Moreover, it bound to lima bean agglutinin-Sepharose specific for N-acetylgalactosamine residues, indicating that B151-TRF is a glycosylated glycoprotein containing N-acetylgalactosamine residues. The role of N-acetylgalactosamine residues on TRF activity was additionally substantiated by the fact that the addition of appropriate amounts of N-acetylgalactosamine in the assay systems for TRF preferentially induced a profound suppression for TRF-mediated PFC responses.
从小鼠T细胞杂交瘤(B151K12)的无细胞上清液中纯化出小鼠T细胞替代因子(TRF),该杂交瘤可组成性产生TRF。采用了两种TRF活性检测系统:1)在经二硝基苯基-钥孔戚血蓝蛋白(DNP-KLH)免疫的BALB/c小鼠脾B细胞培养物中诱导抗DNP IgG空斑形成细胞(PFC)反应;2)在慢性B细胞白血病细胞(BCL1)中诱导IgM PFC。纯化方案包括硫酸铵沉淀、二乙氨基乙基纤维素(DEAE-纤维素)层析、蓝色琼脂糖凝胶层析、羟基磷灰石层析、快速蛋白质液相色谱(FPLC)凝胶渗透和圆盘聚丙烯酰胺凝胶电泳。总体而言,TRF纯化了约34000倍,活性最大回收率为3.8%,纯化后的TRF比活性约为9.6×10⁴U/mg。在这些系统中有活性的TRF与其他淋巴因子不同,如白细胞介素1(IL-1)、白细胞介素2(IL-2)、卡介苗生长因子I(现称为B细胞刺激因子1,BSFp1)和γ干扰素。TRF具有极强的疏水性,在凝胶渗透色谱上的表观分子量为50000至60000,在还原条件下的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)上为18000。高度纯化的B151-TRF经胰蛋白酶处理后活性丧失,但经核糖核酸酶(RNase)处理后活性未丧失。此外,它能与对N-乙酰半乳糖胺残基具有特异性的菜豆凝集素-琼脂糖结合,表明B151-TRF是一种含有N-乙酰半乳糖胺残基的糖基化糖蛋白。在TRF检测系统中加入适量的N-乙酰半乳糖胺会优先对TRF介导的PFC反应产生显著抑制,这一事实进一步证实了N-乙酰半乳糖胺残基对TRF活性的作用。